{"schema_version":"1","generated_at":"2026-11-21T23:53:40.759Z","data_as_of":null,"url":"https://www.findmykol.com/kol/shelby-terstriep","json_url":"https://www.findmykol.com/kol/shelby-terstriep/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"shelby-terstriep","name":"Shelby Terstriep","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Fargo","state":"NC","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"on_file":["npi","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Shelby Terstriep is an Oncology physician. OpenAlex indexes 23 publications with 1,658 citations (h-index 11).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":23,"cited_by_count":1658,"h_index":11,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Gilead Sciences, Inc.","program_year":2021,"amount_usd":11.92,"payment_count":1}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":5,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":57.1,"classes_total":4,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":30.1,"drugs":[{"name":"Anastrozole","share_pct":85.9},{"name":"Letrozole","share_pct":14.1}],"max_beneficiaries":null},{"class":"Estrogen Agonist/Antagonist","setting":"prescribed","share_pct":12.8,"drugs":[{"name":"Tamoxifen Citrate","share_pct":100}],"max_beneficiaries":12}]},{"area":"Metabolism & gastrointestinal","share_pct":15.2,"classes_total":3,"classes":[{"class":"Biguanide (metformin)","setting":"prescribed","share_pct":6,"drugs":[{"name":"Metformin Hcl Er","share_pct":100}],"max_beneficiaries":null},{"class":"GLP-1 receptor agonist","setting":"prescribed","share_pct":5.3,"drugs":[{"name":"Ozempic","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":13.5,"classes_total":2,"classes":[{"class":"Gabapentinoids","setting":"prescribed","share_pct":7.8,"drugs":[{"name":"Gabapentin","share_pct":100}],"max_beneficiaries":null},{"class":"Benzodiazepine","setting":"prescribed","share_pct":5.7,"drugs":[{"name":"Lorazepam","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":23,"shown":5,"withheld":18,"matched_by":"OpenAlex author record","recent":[{"title":"Naloxegol, an Oral Peripherally Acting Opioid Receptor Antagonist, Administered Concurrently with First-Line Systemic Therapy for Advanced Lung Adenocarcinoma (Alliance A221504): A Feasibility and Safety Study","year":2026,"journal":"Cancers","source_url":"https://doi.org/10.3390/cancers18030373","status":"verified"},{"title":"Oncology patient and provider preferences regarding rapid radiology result release to online portals.","year":2021,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2021.39.15_suppl.1544","status":"verified"},{"title":"A Rare Case of Diffuse Pulmonary Arteriovenous Malformations Secondary to Placental Site Trophoblastic Tumor","year":2021,"source_url":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4928","status":"verified"},{"title":"Pilot study of fractional CO2 laser therapy for genitourinary syndrome of menopause in gynecologic cancer survivors","year":2020,"journal":"Maturitas","source_url":"https://doi.org/10.1016/j.maturitas.2020.10.018","status":"verified"},{"title":"A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102","year":2020,"journal":"Supportive Care in Cancer","source_url":"https://doi.org/10.1007/s00520-020-05473-2","status":"verified"}],"source":"works"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":18}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}